Status:
RECRUITING
Goals in Focus: CBT for Motivational Negative Symptoms of Psychosis
Lead Sponsor:
University of Hamburg-Eppendorf
Conditions:
Psychosis
Schizophrenia
Eligibility:
All Genders
16-85 years
Phase:
NA
Brief Summary
This pilot feasibility trial aims to evaluate the "Goals in Focus" intervention for motivational negative symptoms in people with psychosis. Goals in Focus interventions translate findings of basic c...
Detailed Description
The reduction of goal-directed behavior is a core issue in motivational negative symptoms of psychosis and accounts for the long-term decline in psychological wellbeing and psychosocial functioning. H...
Eligibility Criteria
Inclusion
- ICD-10 diagnosis of a schizophrenia spectrum disorder (confirmed by the Structured Clinical Interview for DSM V Clinical Version
- at least moderate motivational negative symptoms (i.e., scores ≥ 3 (moderate) in two items or ≥ 4 (moderately severe) in one item of the 'motivation and pleasure factor' of the Brief Negative Symptom Scale (BNSS)
- sufficient skills in German language to participate in psychological therapy
- capable to engage in weekly therapy sessions of 50-minutes
- prioritize the reduction of negative symptoms as their current goal for treatment
- capable to give informed consent to participate in the trial
Exclusion
- being at immediate and serious risk to self or others
- co-morbid diagnosis of alcohol or substance use disorder
- intake of Benzodiazepines for \>2 days per week
- receiving any other psychological treatment aiming to reduce motivational negative symptoms
Key Trial Info
Start Date :
March 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05252039
Start Date
March 1 2020
End Date
December 1 2024
Last Update
May 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Psychotherapeutische Hoschschulambulanz Universität Hamburg
Hamburg, Germany, 20146